Dang Q, Brown B S, van Poelje P D, Colby T J, Erion M D
Department of Medicinal Chemistry, Metabasis Therapeutics, Inc., San Diego, CA 92121, USA.
Bioorg Med Chem Lett. 1999 Jun 7;9(11):1505-10. doi: 10.1016/s0960-894x(99)00239-5.
A new prodrug approach for intracellular delivery of phosphonates was developed via the synthesis of 3-phthalidyl esters of 1-naphthalenemethylphosphonate. This approach is advantageous over the traditional acyloxymethyl phosphonate prodrugs, because these prodrugs do not generate formaldehyde and have improved plasma half-lives.
通过合成1-萘甲基膦酸酯的3-邻苯二甲酰亚胺酯,开发了一种用于膦酸盐细胞内递送的新前药方法。这种方法优于传统的酰氧基甲基膦酸酯前药,因为这些前药不会产生甲醛,并且具有更长的血浆半衰期。